Cargando…

Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression

Chaperone-usher (CU) fimbriae are the most abundant Gram-negative bacterial fimbriae, with 38 distinct CU fimbria types described in Escherichia coli alone. Some E. coli CU fimbriae have been well characterized and bind to specific glycan targets to confer tissue tropism. For example, type 1 fimbria...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, Christopher J., Lo, Alvin W., Hartley-Tassell, Lauren E., Argente, M. Pilar, Poole, Jessica, King, Nathan P., Tiralongo, Joe, Jennings, Michael P., Schembri, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545135/
https://www.ncbi.nlm.nih.gov/pubmed/33622724
http://dx.doi.org/10.1128/mBio.03664-20
_version_ 1784589958152978432
author Day, Christopher J.
Lo, Alvin W.
Hartley-Tassell, Lauren E.
Argente, M. Pilar
Poole, Jessica
King, Nathan P.
Tiralongo, Joe
Jennings, Michael P.
Schembri, Mark A.
author_facet Day, Christopher J.
Lo, Alvin W.
Hartley-Tassell, Lauren E.
Argente, M. Pilar
Poole, Jessica
King, Nathan P.
Tiralongo, Joe
Jennings, Michael P.
Schembri, Mark A.
author_sort Day, Christopher J.
collection PubMed
description Chaperone-usher (CU) fimbriae are the most abundant Gram-negative bacterial fimbriae, with 38 distinct CU fimbria types described in Escherichia coli alone. Some E. coli CU fimbriae have been well characterized and bind to specific glycan targets to confer tissue tropism. For example, type 1 fimbriae bind to α-d-mannosylated glycoproteins such as uroplakins in the bladder via their tip-located FimH adhesin, leading to colonization and invasion of the bladder epithelium. Despite this, the receptor-binding affinity of many other E. coli CU fimbria types remains poorly characterized. Here, we used a recombinant E. coli strain expressing different CU fimbriae, in conjunction with glycan array analysis comprising >300 glycans, to dissect CU fimbria receptor specificity. We initially validated the approach by demonstrating the purified FimH lectin-binding domain and recombinant E. coli expressing type 1 fimbriae bound to a similar set of glycans. This technique was then used to map the glycan binding affinity of six additional CU fimbriae, namely, P, F1C, Yqi, Mat/Ecp, K88, and K99 fimbriae. The binding affinity was determined using whole-bacterial-cell surface plasmon resonance. This work describes new information in fimbrial specificity and a rapid and scalable system to define novel adhesin-glycan interactions that underpin bacterial colonization and disease.
format Online
Article
Text
id pubmed-8545135
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-85451352021-10-27 Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression Day, Christopher J. Lo, Alvin W. Hartley-Tassell, Lauren E. Argente, M. Pilar Poole, Jessica King, Nathan P. Tiralongo, Joe Jennings, Michael P. Schembri, Mark A. mBio Research Article Chaperone-usher (CU) fimbriae are the most abundant Gram-negative bacterial fimbriae, with 38 distinct CU fimbria types described in Escherichia coli alone. Some E. coli CU fimbriae have been well characterized and bind to specific glycan targets to confer tissue tropism. For example, type 1 fimbriae bind to α-d-mannosylated glycoproteins such as uroplakins in the bladder via their tip-located FimH adhesin, leading to colonization and invasion of the bladder epithelium. Despite this, the receptor-binding affinity of many other E. coli CU fimbria types remains poorly characterized. Here, we used a recombinant E. coli strain expressing different CU fimbriae, in conjunction with glycan array analysis comprising >300 glycans, to dissect CU fimbria receptor specificity. We initially validated the approach by demonstrating the purified FimH lectin-binding domain and recombinant E. coli expressing type 1 fimbriae bound to a similar set of glycans. This technique was then used to map the glycan binding affinity of six additional CU fimbriae, namely, P, F1C, Yqi, Mat/Ecp, K88, and K99 fimbriae. The binding affinity was determined using whole-bacterial-cell surface plasmon resonance. This work describes new information in fimbrial specificity and a rapid and scalable system to define novel adhesin-glycan interactions that underpin bacterial colonization and disease. American Society for Microbiology 2021-02-23 /pmc/articles/PMC8545135/ /pubmed/33622724 http://dx.doi.org/10.1128/mBio.03664-20 Text en Copyright © 2021 Day et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Day, Christopher J.
Lo, Alvin W.
Hartley-Tassell, Lauren E.
Argente, M. Pilar
Poole, Jessica
King, Nathan P.
Tiralongo, Joe
Jennings, Michael P.
Schembri, Mark A.
Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title_full Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title_fullStr Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title_full_unstemmed Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title_short Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression
title_sort discovery of bacterial fimbria–glycan interactions using whole-cell recombinant escherichia coli expression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545135/
https://www.ncbi.nlm.nih.gov/pubmed/33622724
http://dx.doi.org/10.1128/mBio.03664-20
work_keys_str_mv AT daychristopherj discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT loalvinw discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT hartleytasselllaurene discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT argentempilar discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT poolejessica discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT kingnathanp discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT tiralongojoe discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT jenningsmichaelp discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression
AT schembrimarka discoveryofbacterialfimbriaglycaninteractionsusingwholecellrecombinantescherichiacoliexpression